What is the current size and annual growth rate of the porcine vaccine market?
The porcine vaccine market size has grown strongly in recent years. It will grow from $1.89 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to disease outbreaks and control measures, global increase in pork consumption, intensification of pig farming, government initiatives for disease control, awareness and education programs.
The porcine vaccine market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to global expansion of pig farming, rising disease challenges, stringent regulations and compliance, technological advancements in vaccine development, global trade and disease risk mitigation. Major trends in the forecast period include customization of vaccines for regional challenges, integration of biotechnology in vaccine development, rising concerns about zoonotic diseases, application of genomic approaches in vaccine design, growing investments in research and development.
Get Your Free Sample of The Global Porcine Vaccine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp
How has the porcine vaccine market evolved, and what factors have shaped its growth?
The increasing infection of swine disease will propel the growth of the porcine vaccine market going forward. Swine influenza (swine flu) is a respiratory illness that affects pigs commonly caused by the type A influenza virus, which frequently causes influenza outbreaks in pigs. Porcine vaccines are instilled into pigs, where the pigs’ immune systems react to the vaccine and recall the pathogenic agent by inducing an immunogenic reaction. These vaccines prepare the swine’s immune system to fight against pathogens and prevent the sickness by exerting an anamnestic reaction when encountering the same pathogen. For instance, in September 2024, according to the Government of the United Kingdom, a UK-based information website, an outbreak of African swine fever (ASF) could severely affect the UK’s £8 billion pig industry, as well as its £600 million annual exports of pork and pork products. The estimated financial impact of such an outbreak could range from £10 million to £100 million. Therefore, the rising infection of swine disease is driving the porcine vaccine market.
What are the major segments of the porcine vaccine market?
The porcine vaccine market covered in this report is segmented –
1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines
2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications
3) By End User: Veterinary Hospitals, Hog or Pig Production Farm
Subsegments:
1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines
2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines
3) By Toxoid Vaccines: Inactivated Toxins
4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines
5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines
6) By DNA Vaccines: Plasmid DNA Vaccines
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report
Which companies dominate the porcine vaccine market?
Major companies operating in the porcine vaccine market include Sanofi Pasteur Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Arko Laboratories Limited, Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., Ringpu Bio-Pharmacy Co Ltd., IDT Biologika GmbH, Bimeda Holdings PLC, Jinyu Bio-Technology Co Ltd., Biogénesis Bagó, Pharmaq AS, Veterquimica S.A., Kyoto Biken Laboratories Inc., Dopharma Research B.V., Agrovet Market Animal Health Ltd., Innovad SA, PBS Animal Health, Merial Animal Health, Aptimmune Biologics Inc., Syntex SA de CV, Zoovet S.A., Shenzhen Weierkang Xiang Animal Pharm Co Ltd., Wuhan Keqian Biology Co Ltd., Anicon Labor GmbH
How will evolving trends contribute to the growth of the porcine vaccine market?
Major companies operating in the porcine vaccine market are adapting strategic partnerships to enhance their research and development capabilities and strengthen their competitive position in the rapidly evolving animal health industry. The collaboration makes use of TVG’s experience in vaccine technology and Pirbright’s expertise in African swine fever (ASF) research. The goal of this partnership is to improve the vaccine development process and develop novel approaches that have the potential to greatly improve swine health. For instance, in May 2024, The Pirbright Institute, a UK-based research institute, partnered with The Vaccine Group (TVG), a UK-based company, to develop a vaccine for African swine fever (ASF), The research aims to develop vaccines to prevent African swine fever (ASF) by using bovine herpesvirus 4 (BoHV-4) as a foundation. This method takes advantage of the latest breakthroughs in ASF vaccine research and pig immunology to design more efficient vaccines. The initiative is funded by the U.K.’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).
What are the key regional dynamics of the porcine vaccine market, and which region leads in market share?
The countries covered in the porcine vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
What Does The Porcine Vaccine Market Report 2025 Offer?
The porcine vaccine market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Porcine vaccines are a medical and pharmaceutical treatment that improves the health of pigs by shielding them from different bacteria, viruses, and other infections. It is used to increase the efficacy of protecting pigs from harmful ailments while increasing the output of top-notch meat for human consumption.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9111
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
